Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Richman

Showing results (21-30 of 314) with videos related to

Pageof 32
Sort By:
Annual Review of Pharmacology and Toxicology|January 1, 1993
HIV drug resistanceD D Richman
Antiviral Therapy|August 9, 2001
Antiretroviral activity of emtricitabine, a potent nucleoside reverse transcriptase inhibitorD D Richman
The New England Journal of Medicine|January 18, 1979
Use of temperature-sensitive mutants for live, attenuated influenza-virus vaccinesD D Richman
Science (New York, N.Y.)|June 28, 1996
HIV therapeuticsD D Richman
AIDS (London, England)|January 1, 1991
Antiretroviral drug resistanceD D Richman
Annual Review of Medicine|January 1, 1991
Antiviral therapy of HIV infectionD D Richman
Research in Virology|March 1, 1992
The clinical significance of drug-resistance mutants of human immunodeficiency virusD D Richman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1995
Clinical significance of drug resistance in human immunodeficiency virusD D Richman
Advances in Experimental Medicine and Biology|January 1, 1996
Antiretroviral drug resistance: mechanisms, pathogenesis, clinical significanceD D Richman
Hepatology (Baltimore, Md.)|September 26, 2000
The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis BD D Richman
Pageof 32

Showing results (21-30 of 314) with videos related to

Sort By:
Pageof 32
Annual Review of Pharmacology and Toxicology|January 1, 1993
HIV drug resistanceD D Richman
Antiviral Therapy|August 9, 2001
Antiretroviral activity of emtricitabine, a potent nucleoside reverse transcriptase inhibitorD D Richman
The New England Journal of Medicine|January 18, 1979
Use of temperature-sensitive mutants for live, attenuated influenza-virus vaccinesD D Richman
Science (New York, N.Y.)|June 28, 1996
HIV therapeuticsD D Richman
AIDS (London, England)|January 1, 1991
Antiretroviral drug resistanceD D Richman
Annual Review of Medicine|January 1, 1991
Antiviral therapy of HIV infectionD D Richman
Research in Virology|March 1, 1992
The clinical significance of drug-resistance mutants of human immunodeficiency virusD D Richman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1995
Clinical significance of drug resistance in human immunodeficiency virusD D Richman
Advances in Experimental Medicine and Biology|January 1, 1996
Antiretroviral drug resistance: mechanisms, pathogenesis, clinical significanceD D Richman
Hepatology (Baltimore, Md.)|September 26, 2000
The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis BD D Richman
Pageof 32